Stephen P. Anthony
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
Papers in
- Oncology 30
- Cancer Treatment and Pharmacology 13
- Pancreatic and Hepatic Oncology Research 7
- HER2/EGFR in Cancer Research 6
-
- Cancer therapeutics and mechanisms 9
- Co-authors
- Donald Richards (6 shared papers)Daniel D. Von Hoff (10 shared papers)Svetislava J. Vukelja (3 shared papers)Gayle Jameson (8 shared papers)David Loesch (5 shared papers)Mitesh J. Borad (3 shared papers)Peter J. Rosen (5 shared papers)Cristian Fernández (1 shared paper)
- Journals
- Journal of Clinical Oncology (21 papers)Blood (9 papers)Clinical Cancer Research (3 papers)Investigational New Drugs (2 papers)HemaSphere (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Stephen P. Anthony
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 603
- Oncology 881
- Pulmonary and Respiratory Medicine 368
- Pathology and Forensic Medicine 199
- Genetics 83
Countries citing papers authored by Stephen P. Anthony
This map shows the geographic impact of Stephen P. Anthony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Anthony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Anthony more than expected).
Fields of papers citing papers by Stephen P. Anthony
This network shows the impact of papers produced by Stephen P. Anthony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Anthony. The network helps show where Stephen P. Anthony may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen P. Anthony, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 434 | |
| 2 | 2006 | 390 | |
| 3 | 2007 | 74 | |
| 4 | 2009 | 70 | |
| 5 | 2014 | 57 | |
| 6 | 2006 | 53 | |
| 7 | 2012 | 43 | |
| 8 | 2012 | 41 | |
| 9 | 2014 | 40 | |
| 10 | 2014 | 33 | |
| 11 | 2015 | 27 | |
| 12 | 2012 | 26 | |
| 13 | Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice. | 1999 | 21 |
| 14 | 2020 | 18 | |
| 15 | 2014 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2014 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 2017 | 8 |
About Stephen P. Anthony
Stephen P. Anthony is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 53 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Cancer therapeutics and mechanisms (9 papers), Acute Myeloid Leukemia Research (8 papers), Cancer Genomics and Diagnostics (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Advanced Breast Cancer Therapies (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Cancer Research (603 citations), Oncology (881 citations), Pulmonary and Respiratory Medicine (368 citations), Pathology and Forensic Medicine (199 citations) and Genetics (83 citations). Stephen P. Anthony has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Donald Richards, Daniel D. Von Hoff, Svetislava J. Vukelja, Gayle Jameson, David Loesch, Mitesh J. Borad, Peter J. Rosen, Cristian Fernández, Susan B. Brown and Michael Bittner. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Investigational New Drugs and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.